Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.72 CAD | -7.00% | -4.12% | -5.82% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.82% | 86.75M | |
+23.70% | 74.04B | |
-1.65% | 24.18B | |
+3.42% | 8.46B | |
+9.92% | 8.34B | |
-23.66% | 7.64B | |
+13.06% | 5.33B | |
+2.27% | 4.12B | |
-6.90% | 3.92B | |
+3.99% | 3.89B |
- Stock Market
- Equities
- HLS Stock
- News HLS Therapeutics Inc.
- HLS Therapeutics Brief: Q1 2024 revenue was US$12.5 million, Adjusted EBITDA was $2.7 million and cash from operations was $0.8 million